folic acid has been researched along with Parkinson Disease in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (4.62) | 18.7374 |
| 1990's | 1 (1.54) | 18.2507 |
| 2000's | 31 (47.69) | 29.6817 |
| 2010's | 20 (30.77) | 24.3611 |
| 2020's | 10 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, B | 1 |
| Adarmes-Gómez, AD; Bonilla-Toribio, M; Buiza-Rueda, D; Gómez-Garre, P; Jesús, S; Jimenez-Jaraba, MV; Macías-García, D; Martín-Rodríguez, JF; Mir, P; Muñoz-Delgado, L; Periñán, MT | 1 |
| Boldt, ABW; Dos Santos, PI; Kretzschmar, GC; Lima, MMS; Macedo, DA; Ribeiro Pinto, LF; Rodrigues, LS; Soares-Lima, SC; Targa, ADS | 1 |
| Ascherio, A; Bjornevik, K; Blacker, D; Christine, CW; Flores-Torres, MH; Healy, BC; Hung, AY; Molsberry, SA; Schwarzschild, MA | 1 |
| Gou, M; Guo, X; Liu, Y | 1 |
| Ares-Pensado, B; Castro, A; Fernandez-Pajarin, G; Rivero-de-Aguilar, A; Sesar, A | 1 |
| Dong, B; Wu, R | 1 |
| Bedarf, J; Bidkhori, G; Ehrlich, SD; Hildebrand, F; Le Chatelier, E; Lee, S; Mardinoglu, A; Proctor, G; Rosario, D; Shoaie, S; Uhlen, M; Wüllner, U | 1 |
| Anamnart, C; Kitjarak, R | 1 |
| de Almeida, AG; Finsterer, J; Rodrigues, AM; Scorza, CA; Scorza, FA | 1 |
| Guo, N; Liu, X; Tian, D; Zhang, C; Zhang, J; Zhao, Y; Zhu, R | 1 |
| Artuch, R; Cardellach, F; Catalán-García, M; Esteve-Codina, A; Ezquerra, M; Fernández-Santiago, R; Garrabou, G; González-Casacuberta, I; Guitart-Mampel, M; Juárez-Flores, DL; Martí, MJ; Milisenda, JC; Morén, C; Pont-Sunyer, C; Sierra, C; Tobías, E; Tolosa, E | 1 |
| Dong, ZF; Huang, JY; Liu, CF; Pan, PL; Shen, Y; Xu, G | 1 |
| Jadavji, NM; Murray, LK | 1 |
| Martey, J; Rajabally, YA | 1 |
| Nyholm, D; Rahne, KE; Tagesson, C | 1 |
| Antonini, A; Calandrella, D; Cantello, R; Coletti Moja, M; Comi, C; Dal Fante, M; Lacerenza, M; Mancini, F; Manfredi, L; Oggioni, GD; Pacchetti, C; Riboldazzi, G; Tunesi, S | 1 |
| Singh, SK; Srikrishna, S; Srivastav, S; Yadav, AK | 2 |
| Shen, L | 1 |
| Bauer, A; Bührle, CP; Freund, HJ; Hardenacke, K; Häussermann, P; Hellmich, M; Klosterkötter, J; Kuhn, J; Lenartz, D; Maarouf, M; Noreik, M; Schulz, RJ; Sturm, V; Visser-Vandewalle, V; Wiltfang, J | 1 |
| Feng, H; Peng, S; Xiao, J; Xie, Y; Zhang, J | 1 |
| Celardo, I; Costa, AC; Lehmann, S; Loh, SH; Miguel Martins, L | 1 |
| Bouchard, TP; Camicioli, RM; Somerville, MJ | 1 |
| Barchak, AG; Busanello, EN; Camargo, D; Carrion, MJ; da Costa, JC; Dalbem, A; de Mello Rieder, CR; de Sousa Miguel, SR; dos Santos, EF; Miglioranza, A; Rosa, C; Saute, J; Vargas, CR; Wajner, M; Zanatta, A | 1 |
| Bescos, E; Clavero, P; García-Garcia, D; Irigoien, J; Irurzun, C; Kulisevsky, J; Lage, PM; Lamet, I; Matsubara, JM; Obeso, JA; Pagonabarraga, J; Pérez-Tur, J; Rodriguez-Oroz, MC; Samaranch, L; Sanchez-Mut, J; Toledo, JB | 1 |
| Dillmann, U; Fassbender, K; Herrmann, W; Kostopoulos, P; Obeid, R; Schadt, A | 1 |
| Fukushima, W; Fukuyama, H; Hirota, Y; Kawamura, N; Kiyohara, C; Miki, T; Miyake, Y; Murakami, K; Nagai, M; Oeda, T; Sakae, N; Sasaki, S; Tanaka, K; Tsuboi, Y; Yamada, T | 1 |
| Bötzel, K; Giese, A; Levin, J; Lorenzl, S; Vogeser, M | 1 |
| de la Fuente-Fernández, R; Grande, M; Llaneza, M; Macías, M; Santos-García, D | 1 |
| Ådén, E; Carlsson, M; Edström, M; Forsgren, L; Håglin, L; Linder, J; Poortvliet, E; Stenlund, H | 1 |
| Belcastro, V; Caccamo, D; Calabresi, P; Currò, M; Ferlazzo, N; Gorgone, G; Ientile, R; Parisi, G; Parnetti, L; Pisani, F; Rossi, A; Tambasco, N | 1 |
| Ak, F; Arli, B; Bilen, S; Madenci, G; Saka, M | 1 |
| Białecka, M; Budrewicz, S; Droździk, M; Gorzkowska, A; Gołąb-Janowska, M; Honczarenko, K; Jarosz, M; Koziorowska-Gawron, E; Kurzawski, M; Mak, M; Robowski, P; Roszmann, A; Sitek, EJ; Sławek, J | 1 |
| Artner-Dworzak, E; Frick, B; Fuchs, D; Laich, A; Leblhuber, F; Widner, B | 1 |
| Diaz-Arrastia, R; Frol, AB; Rogers, JD; Sanchez-Saffon, A | 1 |
| Mattson, MP; Shea, TB | 1 |
| Mattson, MP | 1 |
| Kuhn, W; Müller, T; Woitalla, D | 2 |
| Feldman, RG; Miller, JW; Nadeau, MR; Selhub, J; Thomas, CA; Wolf, PA | 1 |
| Sachdev, P | 1 |
| Ascherio, A; Chen, H; Hernán, MA; Logroscino, G; Schwarzschild, MA; Willett, WC; Zhang, SM | 1 |
| Armenise, E; de Mari, M; Fraddosio, A; Iliceto, G; Lamberti, P; Livrea, P; Zoccolella, S | 1 |
| Bottiglieri, T; Dewey, RB; Diaz-Arrastia, R; O'Suilleabhain, PE; Sharma, S | 1 |
| Armenise, E; de Mari, M; Fraddosio, A; Iliceto, G; Lamberti, P; Lamberti, SV; Livrea, P; Mastronardi, R; Zoccolella, S | 1 |
| Armenise, E; de Mari, M; Fraddosio, A; Iliceto, G; Lamberti, P; Lamberti, SV; Livrea, P; Zoccolella, S | 1 |
| Benetin, J; Blazícek, P; Gmitterová, K; Kukumberg, P; Valkovic, P; Valkovicová, L | 1 |
| Bottiglieri, T; Diaz-Arrastia, R; Greenberg, SM; Growdon, JH; Gurol, ME; Hyman, BT; Irizarry, MC; Locascio, JJ; Raju, S; Tennis, M | 1 |
| Barcikowska, M; Chodakowska-Zebrowska, M; Czyzewski, K; Lokk, J; Peplonska, B; Religa, D; Stepien, K; Styczynska, M; Winblad, B | 1 |
| Camicioli, R; Espay, AJ; Lafontaine, AL; Lang, AE; Martin, WR; Postuma, RB; Ranawaya, R; Suchowersky, O; Zadikoff, C | 1 |
| Breteler, MM; de Lau, LM; Hofman, A; Koudstaal, PJ; Witteman, JC | 1 |
| Aydemir, T; Cetin, S; Hanoglu, L; Koldas, M; Meral, H; Ozer, F; Ozturk, O; Seval, H; Yilsen, M | 1 |
| Di Rocco, A; Werner, P | 1 |
| Angelopoulos, E; Boufidou, F; Evangelopoulos, ME; Kararizou, E; Nikolaou, C; Triantafyllou, NI; Tsounis, S; Vassilopoulos, D | 1 |
| Balk, E; Chew, P; Chung, M; DeVine, D; Ip, S; Lau, J; Raman, G; Tatsioni, A | 1 |
| Herrmann, W; Lorenzl, S; Obeid, R | 1 |
| Armstrong, VW; Bachmann, CG; Guth, N; Happe, S; Helmschmied, K; Paulus, W | 1 |
| Belcastro, V; Caccamo, D; Calabresi, P; Currò, M; Di Iorio, W; Gorgone, G; Ientile, R; Menichetti, C; Parisi, G; Parnetti, L; Pisani, F; Rossi, A | 1 |
| Angelopoulos, E; Boufidou, F; Evangelopoulos, ME; Kararizou, E; Nikolaou, C; Rentzos, M; Triantafyllou, NI; Vassilopoulos, D | 1 |
| Ben-Shlomo, Y; Davey-Smith, G; Harmon, DL; Ramsbottom, D; Whitehead, AS | 1 |
| Kowa, H; Nakashima, K; Nakaso, K; Takeshima, T; Yasui, K | 1 |
| Tzavellas, O | 1 |
| McGeer, EG; McGeer, PL; Zeldowicz, L | 1 |
| Cawein, MJ | 1 |
10 review(s) available for folic acid and Parkinson Disease
| Article | Year |
|---|---|
Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease.
Topics: Case-Control Studies; Cognitive Dysfunction; Folic Acid; Genetic Background; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Parkinson Disease; Vitamin B 12 | 2023 |
Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis.
Topics: Cognitive Dysfunction; Folic Acid; Homocysteine; Humans; Parkinson Disease; Vitamin B 12 | 2023 |
Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.
Topics: Case-Control Studies; China; Folic Acid; Homocysteine; Humans; Parkinson Disease; Vitamin B 12 | 2020 |
The role of one-carbon metabolism and homocysteine in Parkinson's disease onset, pathology and mechanisms.
Topics: Animals; Diet; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Levodopa; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Nutritional Status; One-Carbon Group Transferases; Parkinson Disease; Polymorphism, Genetic; Vitamin B Complex | 2019 |
Associations between B Vitamins and Parkinson's Disease.
Topics: Case-Control Studies; Diet; Folic Acid; Humans; Odds Ratio; Parkinson Disease; Protective Factors; Risk Assessment; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2015 |
Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Cognition; Cognition Disorders; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Vitamin B 12 | 2017 |
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.
Topics: Aging; Alzheimer Disease; Animals; Apoptosis; Cell Death; Depressive Disorder; Folic Acid; Homocysteine; Humans; Mental Disorders; Methylation; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Parkinson Disease; Schizophrenia; Stroke | 2003 |
[Homocysteine and neuropsychiatric disorders].
Topics: Alzheimer Disease; Dementia, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Mental Disorders; Parkinson Disease; Risk Factors; Stroke; Vitamin B 12; Vitamin B 6 | 2004 |
B vitamins and berries and age-related neurodegenerative disorders.
Topics: Aging; Alzheimer Disease; Animals; Blueberry Plants; Cognition; Disease Models, Animal; Folic Acid; Fragaria; Fruit; Humans; Neurodegenerative Diseases; Parkinson Disease; Plant Extracts; Riboflavin; Thiamine; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2006 |
[Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
Topics: Aged; Central Nervous System; Child; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Mental Disorders; Nervous System Diseases; Parkinson Disease; Risk Factors; Vitamin B 12; Vitamin B Deficiency | 2007 |
12 trial(s) available for folic acid and Parkinson Disease
| Article | Year |
|---|---|
Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
Topics: Aged; Antiparkinson Agents; Catechols; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Research Design; Vitamin B 12 | 2021 |
Parkinson's disease: Research puts spotlight on thiamine deficiency and cardiovascular health.
Topics: Folic Acid; Homocysteine; Humans; Levodopa; Parkinson Disease; Thiamine Deficiency; Vitamin B 12 | 2021 |
Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study.
Topics: Aged; Alzheimer Disease; Basal Nucleus of Meynert; Body Composition; Body Weight; Cognition; Deep Brain Stimulation; Diet Records; Female; Folic Acid; Humans; Male; Middle Aged; Nutritional Status; Parkinson Disease; Pilot Projects; Vitamin B 12 | 2015 |
Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.
Topics: Antiparkinson Agents; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Pyridoxal Phosphate; Risk Factors; Vitamin B 12; Vitamin B Complex | 2003 |
Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Catechols; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Levodopa; Linear Models; Male; Middle Aged; Nitriles; Parkinson Disease; Vitamin B 12 | 2005 |
Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications.
Topics: Aged; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Vitamin B 12 | 2005 |
Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
Topics: Aged; Antiparkinson Agents; Canada; Catechols; Double-Blind Method; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Placebo Effect; Treatment Outcome; United States; Vitamin B 12; Vitamins | 2006 |
Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.
Topics: Administration, Oral; Cohort Studies; Diet Therapy; Dietary Supplements; Female; Folic Acid; Humans; Incidence; Male; Middle Aged; Netherlands; Parkinson Disease; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2006 |
Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Cognition; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Statistics, Nonparametric; Vitamin B 12 | 2006 |
The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson's disease patients.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Catechols; Female; Folic Acid; Humans; Immunoassay; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Vitamin B 12 | 2007 |
Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognition.
Topics: Affect; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Cognition; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Vitamin B 12 | 2008 |
A clinical trial of folic acid in Parkinson's disease.
Topics: Administration, Oral; Animals; Brain; Clinical Trials as Topic; Coenzymes; Folic Acid; Humans; Parkinson Disease; Rats; Tyrosine 3-Monooxygenase | 1972 |
43 other study(ies) available for folic acid and Parkinson Disease
| Article | Year |
|---|---|
Commentary on Severe Hyperhomocysteinemia in a Patient with Parkinson Disease.
Topics: Folic Acid; Humans; Hyperhomocysteinemia; Parkinson Disease; Vitamin B 12 | 2022 |
Folic Acid and Vitamin B12 Prevent Deleterious Effects of Rotenone on Object Novelty Recognition Memory and
Topics: Animals; Disease Models, Animal; Folic Acid; Parkinson Disease; Rats; Rotenone; Vitamin B 12 | 2022 |
Long-Term Intake of Folate, Vitamin B6, and Vitamin B12 and the Incidence of Parkinson's Disease in a Sample of U.S. Women and Men.
Topics: Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Humans; Incidence; Male; Parkinson Disease; Risk Factors; Vitamin B 12; Vitamin B 6 | 2023 |
[Chronic inflammatory demyelinating polyradiculoneuropathy associated with treatment using intraduodenal infusion of levodopa-carbidopa].
Topics: Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Dopamine; Drug Combinations; Duodenum; Female; Folic Acid; Humans; Infusions, Parenteral; Levodopa; Metabolic Networks and Pathways; Methionine; Middle Aged; Parkinson Disease; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2019 |
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
Topics: Aged; Bacteria; Case-Control Studies; Databases, Genetic; Dysbiosis; Folic Acid; Folic Acid Deficiency; Gastrointestinal Microbiome; Homocysteine; Humans; Hyperhomocysteinemia; Intestines; Male; Metabolome; Metabolomics; Metagenome; Metagenomics; Middle Aged; Mucins; Parkinson Disease; Polysaccharides; Severity of Illness Index | 2021 |
Investigating the causality of metabolites involved in one-carbon metabolism with the risk and age at onset of Parkinson's disease: A two-sample mendelian randomization study.
Topics: Age of Onset; Dietary Supplements; Disease Susceptibility; Folic Acid; Genome-Wide Association Study; Homocysteine; Mendelian Randomization Analysis; Negative Results; Parkinson Disease; Risk; Vitamin B 12; Vitamin B 6 | 2021 |
Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
Topics: Adult; Aged; Amino Acids; Cell Adhesion; Cell Growth Processes; Cells, Cultured; Child; Female; Fibroblasts; Folic Acid; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Sequence Analysis, RNA; Skin; Transcriptome; Ubiquitin-Protein Ligases | 2018 |
Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
Topics: Aged; Female; Folic Acid; Gait Disorders, Neurologic; Homocysteine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Postural Balance; Severity of Illness Index; White Matter | 2019 |
Levodopa, vitamins, ageing and the neuropathy of Parkinson's disease.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Cross-Sectional Studies; Female; Folic Acid; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Vitamin B 12 | 2013 |
Motor fluctuations and Helicobacter pylori in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Breath Tests; Female; Folic Acid; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Absorption; Levodopa; Male; Parkinson Disease; Treatment Outcome; Vitamin B 12 | 2013 |
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Electromyography; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Peripheral Nervous System Diseases; Prevalence; Vitamin B 12 | 2014 |
Folic acid supplementation rescues anomalies associated with knockdown of parkin in dopaminergic and serotonergic neurons in Drosophila model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Drosophila; Drosophila Proteins; Folic Acid; Gene Knockdown Techniques; Parkinson Disease; Serotonergic Neurons; Ubiquitin-Protein Ligases | 2015 |
Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson's Disease.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Drosophila; Folic Acid; Humans; Introns; Locomotion; Oxidative Stress; Parkinson Disease; RNA, Messenger; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2015 |
dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective.
Topics: Activating Transcription Factor 4; Animals; Drosophila; Drosophila Proteins; Folic Acid; Glycine Hydroxymethyltransferase; Methylenetetrahydrofolate Dehydrogenase (NADP); Mitochondria; Mutagenesis; Neuroprotection; Parkinson Disease; Phenotype; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Ubiquitin-Protein Ligases; Up-Regulation | 2017 |
Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Cognition; Creatinine; Female; Folic Acid; Genotype; Homocysteine; Humans; Inactivation, Metabolic; Levodopa; Male; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Motor Skills; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Vitamin B Complex | 2009 |
Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.
Topics: Analysis of Variance; Case-Control Studies; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Matched-Pair Analysis; Middle Aged; Nerve Degeneration; Parkinson Disease; Reference Values; Statistics, Nonparametric; Vitamin B 12 | 2009 |
Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Aged, 80 and over; Brain; Carbon-Nitrogen Ligases; Case-Control Studies; Cognition Disorders; Cystathionine beta-Synthase; Depression; Female; Folic Acid; Homocysteine; Humans; Immunoassay; Logistic Models; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Polymorphism, Genetic; Severity of Illness Index; Vitamin B 12; Vitamin B 6 | 2009 |
Methylation status and neurodegenerative markers in Parkinson disease.
Topics: Aged; alpha-Synuclein; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Biomarkers; Blood Platelets; Cognition Disorders; Female; Folic Acid; Homocysteine; Humans; Male; Methylation; Middle Aged; Nerve Degeneration; Parkinson Disease; Peptide Fragments; S-Adenosylhomocysteine; S-Adenosylmethionine; Substantia Nigra; Ultrasonography; Vitamin B 6 | 2009 |
Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan.
Topics: Aged; Case-Control Studies; Diet; Diet Surveys; Female; Folic Acid; Humans; Japan; Male; Middle Aged; Odds Ratio; Parkinson Disease; Riboflavin; Risk Factors; Surveys and Questionnaires; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2010 |
Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis.
Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Male; Matched-Pair Analysis; Methylmalonic Acid; Middle Aged; Parkinson Disease; Reference Values; Supranuclear Palsy, Progressive; Vitamin B 12 | 2010 |
Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion.
Topics: Aged; Antiparkinson Agents; Female; Folic Acid; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Thiamine | 2011 |
Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study.
Topics: Aged; Anthropometry; Case-Control Studies; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Intake; Female; Folic Acid; Humans; Magnesium; Male; Middle Aged; Motor Activity; Olfactory Perception; Parkinson Disease; Phosphorus | 2011 |
Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Parkinson Disease; Polymorphism, Genetic; Ubiquinone; Vitamin B 12 | 2012 |
Serum iron, vitamin B12 and folic acid levels in Parkinson's disease.
Topics: Aged; Case-Control Studies; Female; Folic Acid; Humans; Iron; Male; Middle Aged; Parkinson Disease; Vitamin B 12 | 2012 |
Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
Topics: Catechol O-Methyltransferase; Cognition Disorders; Female; Folic Acid; Genetic Association Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Parkinson Disease; Polymorphism, Genetic; Reduced Folate Carrier Protein; Vitamin B 12 | 2012 |
Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Neopterin; Parkinson Disease; Vitamin B 12 | 2002 |
Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors; Vitamin B 12 | 2003 |
Will caloric restriction and folate protect against AD and PD?
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Animals; Brain; Brain-Derived Neurotrophic Factor; Caloric Restriction; Disease Models, Animal; Energy Intake; Folic Acid; Homocysteine; Humans; Middle Aged; Neurons; Oxidative Stress; Parkinson Disease; Rats; Risk Factors | 2003 |
Benefit of folic acid supplementation in parkinsonian patients treated with levodopa.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Folic Acid; Hematinics; Humans; Levodopa; Parkinson Disease; Risk Assessment | 2003 |
Folate intake and risk of Parkinson's disease.
Topics: Adult; Cohort Studies; Diet; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Prospective Studies; Reference Values; Risk Factors; United States; Vitamin B 12; Vitamin B 6 | 2004 |
MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cytosine; Female; Folic Acid; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Parkinson Disease; Polymorphism, Genetic; Tetrahydrofolates; Thymine | 2004 |
Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Folic Acid; Humans; Hyperhomocysteinemia; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies; Vitamin B 12 | 2004 |
Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.
Topics: Aged; Antiparkinson Agents; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Parkinson Disease; Vitamin B 12 | 2005 |
Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Cross-Sectional Studies; Drug Therapy, Combination; Enzyme Inhibitors; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Vitamin B 12 | 2005 |
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Brain; Causality; Cerebral Amyloid Angiopathy; Cognition Disorders; Creatinine; Female; Folic Acid; Homocysteine; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Predictive Value of Tests; Vitamin B 12 | 2005 |
Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Reference Values; Vitamin B 12 | 2006 |
Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
Topics: Antiparkinson Agents; Carbon; Catechol O-Methyltransferase Inhibitors; Catechols; Folic Acid; Humans; Hyperhomocysteinemia; Levodopa; Nitriles; Parkinson Disease; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Time Factors; Vitamin B 12; Vitamin B 6 | 2007 |
Homocysteine in restless legs syndrome.
Topics: Aged; Antiparkinson Agents; Catechols; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Reference Values; Restless Legs Syndrome; Vitamin B 12; Vitamin B 6 | 2008 |
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients.
Topics: Aged; Antiparkinson Agents; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Parkinson Disease; Polymorphism, Genetic; Vitamin B 12 | 2007 |
The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson's disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Folic Acid; Genotype; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases; Parkinson Disease | 1997 |
Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cysteine; Female; Folic Acid; Genotype; Homocysteine; Humans; Levodopa; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Parkinson Disease; Point Mutation | 2000 |
[The effect of vitamin B 12 in combination with 4-chlortestosterone acetate on Parkinson's syndrome and hyperkinesia].
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Tolerance; Female; Folic Acid; Humans; Hyperkinesis; Male; Middle Aged; Niacinamide; Parkinson Disease; Pulse; Pyridoxine; Testosterone; Vitamin B 12 | 1967 |
Vitamin preparations for patients with Parkinsonism.
Topics: Anemia, Pernicious; Dihydroxyphenylalanine; Folic Acid; Humans; Parkinson Disease; Vitamins | 1970 |